Integration of genetics and miRNA–target gene network identified disease biology implicated in tissue specificity

Nucleic Acids Research

Volumn 46, Issue 22, 2018, Pages 11898-11909

  Sakaue, Saori ^a,b,c   Hirata, Jun ^a,d   Maeda, Yuichi ^a,e,f   Kawakami, Eiryo ^b,g   Nii, Takuro ^a,e,f   Kishikawa, Toshihiro ^a   Ishigaki, Kazuyoshi ^b   Terao, Chikashi ^b,h,i,j   Suzuki, Ken ^a,b   Akiyama, Masato ^b,k   Suita, Naomasa ^a,l   Masuda, Tatsuo ^a   Ogawa, Kotaro ^a   Yamamoto, Kenichi ^a   Saeki, Yukihiko ^m   Matsushita, Masato ^m,n   Yoshimura, Maiko ^m   Matsuoka, Hidetoshi ^m   Ikari, Katsunori ^o,p   Taniguchi, Atsuo ^o   Yamanaka, Hisashi ^o   Kawaji, Hideya ^b,g   Lassmann, Timo ^g,q   Itoh, Masayoshi ^g   Yoshitomi, Hiroyuki ^j,r   Ito, Hiromu ^j   Ohmura, Koichiro ^j   Forrest, Alistair R R ^g,s   Hayashizaki, Yoshihide ^g   Carninci, Piero ^b,g   Kumanogoh, Atsushi ^a   Kamatani, Yoichiro ^b,t   de Hoon, Michiel ^b,g   Yamamoto, Kazuhiko ^b   Okada, Yukinori ^a,b,e   more..

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TEIJIN PHARMA LIMITED   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

^g RIKEN   (Japan)

^h SHIZUOKA GENERAL HOSPITAL   (Japan)

ⁱ UNIVERSITY OF SHIZUOKA   (Japan)

^j KYOTO UNIVERSITY   (Japan)

^k KYUSHU UNIVERSITY   (Japan)

^l ONO PHARMACEUTICAL CO   (Japan)

^m MINAMI OSAKA GENERAL HOSPITAL   (Japan)

ⁿ SAISEIKAI SENRI HOSPITAL   (Japan)

^o TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^p JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^q UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^r KYOTO UNIVERSITY   (Japan)

^s UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^t KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENETIC ANALYSIS; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPANESE (PEOPLE); PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; TISSUE SPECIFICITY; ALGORITHM; ANTIBODY SPECIFICITY; ASTHMA; BIOLOGY; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; GRAVES DISEASE; HUMAN GENOME; IMMUNOLOGY; METABOLISM; MULTIFACTORIAL INHERITANCE; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

ALGORITHMS; ARTHRITIS, RHEUMATOID; ASTHMA; BIOMARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC LOCI; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GRAVES DISEASE; HUMANS; MICRORNAS; MULTIFACTORIAL INHERITANCE; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 85058920372     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gky1066     Document Type: Article

References (38)

1. Welter,D., MacArthur,J., Morales,J., Burdett,T., Hall,P., Junkins,H., Klemm,A., Flicek,P., Manolio,T., Hindorff,L. et al. (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res., 42, D1001–D1006.
2. Visscher,P.M., Brown,M.A., McCarthy,M.I. and Yang,J. (2012) Five years of GWAS discovery. Am. J. Hum. Genet., 90, 7–24.
3. Trynka,G., Sandor,C., Han,B., Xu,H., Stranger,B.E., Liu,X.S. and Raychaudhuri,S. (2013) Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet., 45, 124–130.
4. Ongen,H., Brown,A.A., Delaneau,O., Panousis,N.I., Nica,A.C. and Dermitzakis,E.T. (2017) Estimating the causal tissues for complex traits and diseases. Nat. Genet., 49, 1676–1683.
5. Martin,P., McGovern,A., Orozco,G., Duffus,K., Yarwood,A., Schoenfelder,S., Cooper,N.J., Barton,A., Wallace,C., Fraser,P. et al. (2015) Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci. Nat. Commun., 6, 10069.
6. Lee,R., Feinbaum,R. and Ambros,V. (2004) A short history of a short RNA. Cell, 116, S89–S92.
7. Lee,R.C. and Ambros,V. (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862–864.
8. Lu,J., Getz,G., Miska,E.A., Alvarez-Saavedra,E., Lamb,J., Peck,D., Sweet-Cordero,A., Ebert,B.L., Mak,R.H., Ferrando,A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834–838.
9. Brest,P., Lapaquette,P., Souidi,M., Lebrigand,K., Cesaro,A., Vouret-Craviari,V., Mari,B., Barbry,P., Mosnier,J.-F., Hébuterne,X. et al. (2011) A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease. Nat. Genet., 43, 242–245.
10. Krützfeldt,J., Rajewsky,N., Braich,R., Rajeev,K.G., Tuschl,T., Manoharan,M. and Stoffel,M. (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438, 685–689.
11. Titze-de-Almeida,R., David,C. and Titze-de-Almeida,S.S. (2017) The race of 10 synthetic RNAi-based drugs to the pharmaceutical market. Pharm. Res., 34, 1339–1363.
12. De Rie,D., Abugessaisa,I., Alam,T., Arner,E., Arner,P., Ashoor,H., Åström,G., Babina,M., Bertin,N., Burroughs,A.M. et al. (2017) An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat. Biotechnol., 35, 872–878.
13. Okada,Y., Muramatsu,T., Suita,N., Kanai,M., Kawakami,E., Iotchkova,V., Soranzo,N. and Inazawa,J. (2016) Significant impact of miRNA – target gene networks on genetics of human complex traits. Sci. Rep., 6, 22223.
14. Ayellet,V.S., Groop,L., Mootha,V.K., Daly,M.J. and Altshuler,D. (2010) Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet., 6, e1001058.
15. Okada,Y., Momozawa,Y., Ashikawa,K., Kanai,M., Matsuda,K., Kamatani,Y., Takahashi,A. and Kubo,M. (2015) Construction of a population-specific HLA imputation reference panel and its application to Graves’ disease risk in Japanese. Nat. Genet., 47, 798–802.
16. Ludwig,N., Leidinger,P., Becker,K., Backes,C., Fehlmann,T., Pallasch,C., Rheinheimer,S., Meder,B., Stähler,C., Meese,E. et al. (2016) Distribution of miRNA expression across human tissues. Nucleic Acids Res., 44, 3865–3877.
17. Nagai,A., Hirata,M., Kamatani,Y., Muto,K., Matsuda,K., Kiyohara,Y., Ninomiya,T., Tamakoshi,A., Yamagata,Z., Mushiroda,T. et al. (2017) Overview of the BioBank Japan Project: Study design and profile. J. Epidemiol., 27, S2–S8.
18. Hirata,M., Kamatani,Y., Nagai,A., Kiyohara,Y., Ninomiya,T., Tamakoshi,A., Yamagata,Z., Kubo,M., Muto,K., Mushiroda,T. et al. (2017) Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases. J. Epidemiol., 27, S9–S21.
19. Aletaha,D., Neogi,T., Silman,A.J., Funovits,J., Felson,D.T., Bingham,C.O., Birnbaum,N.S., Burmester,G.R., Bykerk,V.P., Cohen,M.D. et al. (2010) 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum., 62, 2569–2581.
20. Ziemann,M., Kaspi,A. and El-Osta,A. (2016) Evaluation of microRNA alignment techniques. RNA, 22, 1120–1138.
21. Okada,Y., Wu,D., Trynka,G., Raj,T., Terao,C., Ikari,K., Kochi,Y., Ohmura,K., Suzuki,A., Yoshida,S. et al. (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature, 506, 376–381.
22. Okada,Y., Suzuki,A., Ikari,K., Terao,C., Kochi,Y., Ohmura,K., Higasa,K., Akiyama,M., Ashikawa,K., Kanai,M. et al. (2016) Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis. Am. J. Hum. Genet., 99, 366–374.
23. GTEx Consortium. (2017) Genetic effects on gene expression across human tissues. Nature, 550, 204–213.
24. Lloyd-Jones,L.R., Holloway,A., McRae,A., Yang,J., Small,K., Zhao,J., Zeng,B., Bakshi,A., Metspalu,A., Dermitzakis,M. et al. (2017) The genetic architecture of gene expression in peripheral blood. Am. J. Hum. Genet., 100, 228–237.
25. Zhu,Z., Zhang,F., Hu,H., Bakshi,A., Robinson,M.R., Powell,J.E., Montgomery,G.W., Goddard,M.E., Wray,N.R., Visscher,P.M. et al. (2016) Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet., 48, 481–487.
26. Kanai,M., Tanaka,T. and Okada,Y. (2016) Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set. J. Hum. Genet., 61, 861–866.
27. Lee,S.H., Wray,N.R., Goddard,M.E. and Visscher,P.M. (2011) Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet., 88, 294–305.
28. Bulik-Sullivan,B., Loh,P.R., Finucane,H.K., Ripke,S., Yang,J., Patterson,N., Daly,M.J., Price,A.L., Neale,B.M., Corvin,A. et al. (2015) LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet., 47, 291–295.
29. Wood,A.R., Esko,T., Yang,J., Vedantam,S., Pers,T.H., Gustafsson,S., Chu,A.Y., Estrada,K., Luan,J., Kutalik,Z. et al. (2014) Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet., 46, 1173–1186.
30. DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples (T2D-GENES) Consortium, Mahajan,A., Go,M.J., Zhang,W., Below,J.E., Gaulton,K.J. et al. (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet., 46, 234–244.
31. Osborn,O. and Olefsky,J.M. (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med., 18, 363–374.
32. Finucane,H.K., Bulik-Sullivan,B., Gusev,A., Trynka,G., Reshef,Y., Loh,P.R., Anttila,V., Xu,H., Zang,C., Farh,K. et al. (2015) Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet., 47, 1228–1235.
33. Chen,J.-Q., Papp,G., Szodoray,P. and Zeher,M. (2016) The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun. Rev., 15, 1171–1180.
34. Malmström,V., Catrina,A.I. and Klareskog,L. (2017) The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat. Rev. Immunol., 17, 60–75.
35. Chen,J.-Q., Papp,G., Szodoray,P. and Zeher,M. (2016) The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun. Rev., 15, 1171–1180.
36. Murata,K., Yoshitomi,H., Furu,M., Ishikawa,M., Shibuya,H., Ito,H. and Matsuda,S. (2014) MicroRNA-451 Down-Regulates neutrophil Chemotaxis via p38 MAPK. Arthritis Rheumatol., 66, 549–559.
37. Finucane,H.K., Reshef,Y.A., Anttila,V., Slowikowski,K., Gusev,A., Byrnes,A., Gazal,S., Loh,P.R., Lareau,C., Shoresh,N. et al. (2018) Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet., 50, 621–629.
38. Chou,C.-H., Shrestha,S., Yang,C.-D., Chang,N.-W., Lin,Y.-L., Liao,K.-W., Huang,W.-C., Sun,T.-H., Tu,S.-J., Lee,W.-H. et al. (2018) miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res., 46, D296–D302.